Literature DB >> 31679730

Cystic fibrosis bone disease treatment: Current knowledge and future directions.

Melissa S Putman1, Abeer Anabtawi2, Trang Le3, Vin Tangpricha4, Isabelle Sermet-Gaudelus5.   

Abstract

Bone disease is a frequent complication in adolescents and adults with cystic fibrosis (CF). Early detection and monitoring of bone mineral density and multidisciplinary preventive care are necessary from childhood through adolescence to minimize CF-related bone disease (CFBD) in adult CF patients. Approaches to optimizing bone health include ensuring adequate nutrition, particularly intake of calcium and vitamins D and K, addressing other secondary causes of low bone density such as hypogonadism, encouraging weight bearing exercise, and avoiding bone toxic medications. Of the currently available anti-resorptive or anabolic osteoporosis medications, only bisphosphonates have been studied in individuals with CF. Future studies are needed to better understand the optimal approach for managing CFBD.
Copyright © 2019 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bisphosphonates; Bone mineral density; Cystic fibrosis; Dual energy x-ray absorptiometry; Fracture; Vitamin D

Year:  2019        PMID: 31679730     DOI: 10.1016/j.jcf.2019.08.017

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN: 1569-1993            Impact factor:   5.482


  9 in total

1.  Relationship Between Estrogen Treatment and Skeletal Health in Women With Cystic Fibrosis.

Authors:  Malinda Wu; Erika L Bettermann; Neha Arora; William R Hunt; Courtney McCracken; Vin Tangpricha
Journal:  Am J Med Sci       Date:  2020-06-06       Impact factor: 2.378

Review 2.  [Cystic fibrosis being a polyendocrine disease (Review)].

Authors:  N B Chagay; G Ya Khayt; T M Vdovina; A A Shaforost
Journal:  Probl Endokrinol (Mosk)       Date:  2021-03-30

3.  Oral ethinyl estradiol treatment in women with cystic fibrosis is associated with lower bone mineral density.

Authors:  Malinda Wu; William R Hunt; Melissa S Putman; Vin Tangpricha
Journal:  J Clin Transl Endocrinol       Date:  2020-03-19

4.  Triage for Malnutrition Risk among Pediatric and Adolescent Outpatients with Cystic Fibrosis, Using a Disease-Specific Tool.

Authors:  Dimitrios Poulimeneas; Maria G Grammatikopoulou; Argyri Petrocheilou; Athanasios G Kaditis; Tonia Vassilakou
Journal:  Children (Basel)       Date:  2020-12-04

5.  Prevalence and Impact of Rheumatologic Pain in Cystic Fibrosis Adult Patients.

Authors:  Axelle Schmoll; Claire Launois; Jeanne-Marie Perotin; Bruno Ravoninjatovo; Muriel Griffon; Sophie Carré; Pauline Mulette; Julien Ancel; Jean Hagenburg; François Lebargy; Gaëtan Deslée; Jean-Hugues Salmon; Sandra Dury
Journal:  Front Med (Lausanne)       Date:  2022-02-08

6.  Utilization of the Healthy Eating Index in Cystic Fibrosis.

Authors:  Rosara Milstein Bass; Alyssa Tindall; Saba Sheikh
Journal:  Nutrients       Date:  2022-02-16       Impact factor: 5.717

Review 7.  Auxological and Endocrinological Features in Children and Adolescents with Cystic Fibrosis.

Authors:  Vittorio Ferrari; Vito Terlizzi; Stefano Stagi
Journal:  J Clin Med       Date:  2022-07-13       Impact factor: 4.964

8.  [Osteoporosis in pneumological diseases : Joint guideline of the Austrian Society for Bone and Mineral Research (ÖGKM) and the Austrian Society for Pneumology (ÖGP)].

Authors:  Christian Muschitz; Ralf Harun Zwick; Judith Haschka; Hans Peter Dimai; Martina Rauner; Karin Amrein; Robert Wakolbinger; Peter Jaksch; Ernst Eber; Peter Pietschmann
Journal:  Wien Klin Wochenschr       Date:  2021-06-16       Impact factor: 1.704

9.  Treatment of cystic fibrosis related bone disease.

Authors:  Jagdeesh Ullal; Katherine Kutney; Kristen M Williams; David R Weber
Journal:  J Clin Transl Endocrinol       Date:  2021-12-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.